Functional Shifts in Gut Microbiota and Associated Metabolites Suggest Gut-Brain Axis Dysregulation in Pediatric

Shabana M Shaik1, Gabriele Schiro1, Daniel Laubitz1

  • 1Department of Pediatrics, Daniel Cracchiolo Institute for Pediatric Autoimmune Disease Research, Steele Children's Research Center, University of Arizona, Tucson, AZ 85721, USA.

Microorganisms
|May 27, 2026
PubMed

Insights

Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (PANDAS) show altered gut bacteria and metabolites, indicating disrupted gut-brain axis signaling. This research opens doors for new microbiome-based PANDAS treatments.

Area of Science:

  • Neuroscience
  • Microbiology
  • Immunology

Background:

  • Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (PANDAS) involve neuropsychiatric symptoms and immune dysregulation.
  • The gut-brain axis and host-microbiome interactions are implicated in neuro-immune functions, but their role in PANDAS is unclear.

Purpose of the Study:

  • To investigate the gut microbiome's role in PANDAS pathophysiology.
  • To identify potential microbiome-based biomarkers and therapeutic targets for PANDAS.

Main Methods:

  • Collected microbiome samples from nasal, throat, and stool sites of PANDAS patients and controls.
  • Performed integrated multi-omics analysis (16S rRNA, shotgun metagenomics, UPLC-MS/MS metabolomics) on stool samples.
  • Analyzed gut-brain modules (GBMs) and gut metabolic modules (GMMs).

Main Results:

  • PANDAS cases showed reduced gut microbial diversity and altered composition.
  • Key functional pathways like quorum sensing and GABA biosynthesis were diminished.
  • Perturbed GBMs, GMMs, and disrupted microbe-metabolite networks linked to gut-brain signaling were observed.
  • Metabolomic profiling revealed distinct metabolic profiles with altered neuroactive compounds.

Conclusions:

  • Significant functional shifts in gut microbiota and metabolites suggest gut-brain axis dysregulation in PANDAS.
  • Findings support the development of microbiome-based biomarkers and therapies for PANDAS.

Related Concept Videos

Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Irritable Bowel Syndrome01:23

Irritable Bowel Syndrome

DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...